Skip to main content

Dwarfism

2
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Human BioSciences
Human BioSciencesWV - Martinsburg
2 programs
2
DeslorelinPhase 21 trial
HumatropePhase 21 trial
Active Trials
NCT00001190Completed50Est. Oct 2001
NCT00001343Completed80Est. Oct 2007
Hua Medicine
Hua MedicineChina - Shanghai
1 program
Recombinant Human Growth Hormone InjectionPHASE_31 trial
Active Trials
NCT03535415Unknown68Est. Sep 2021
Merck & Co.
Merck & Co.RAHWAY, NJ
1 program
r-hGHPHASE_41 trial
Active Trials
NCT01157793Completed34Est. Feb 2005

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Merck & Co.r-hGH
Hua MedicineRecombinant Human Growth Hormone Injection
Human BioSciencesHumatrope
Human BioSciencesDeslorelin

Clinical Trials (4)

Total enrollment: 232 patients across 4 trials

A Multicentre, Randomised, Open-label, Controlled Study to Evaluate the Effects of Saizen® on Cardiac Function in Growth Hormone Deficient(GHD) Subjects During the Transition Phase From Childhood to Adulthood

Start: Sep 2003Est. completion: Feb 200534 patients
Phase 4Completed
NCT03535415Hua MedicineRecombinant Human Growth Hormone Injection

A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before Transplantation

Start: Jun 2018Est. completion: Sep 202168 patients
Phase 3Unknown

The Effects of Hormones in Growth Hormone-Treated Girls With Turner Syndrome

Start: Dec 1992Est. completion: Oct 200780 patients
Phase 2Completed

Study of Luteinizing Hormone-Releasing Hormone Analog (LHRHa) in Pubertal Patients With Extreme Short Stature

Start: Nov 1983Est. completion: Oct 200150 patients
Phase 2Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.